(Total Views: 708)
Posted On: 11/18/2020 2:37:22 PM
Post# of 148899
I just have to say... I am pretty excited about where we are right now. Of coarse I have a problem being a optimist and will probably be reminded of that.
After watching Nader’s enthusiasm yesterday and saying that revenue this year is still on the list of great things to happen for us. It’s pretty exciting. The question is... how do we get that revenue? I would like to believe our 75% interim results are powerful enough to unblind them and see where we stand. Either we are getting great results and the road heavily traveled has paid off for us and great things are in our future or we show some average amount of results and we are still saving lives and great things are in our future still. Sounds win/win to me.
Either way, we are on our way to bigger things. The first catalyst or approval will send us on our way to becoming our own pharmaceutical company with so much potential that it is hard to ignore all the possibilities. All the future revenue possibilities are mind boggling.
I invested here with one indication in mind and that was HIV and things have changed dramatically since then with all the possible indications that are possible. I had no idea there would be such a drug like Leronlimab or should I say Virologix.
Getting our first approval speeds up the process of how we go about trialing the other indications and there is so many and that is huge potential.
The old saying is... It takes money to make money. That really holds true as a fledgling pharmaceutical company. Once we can afford to go full tilt on other trials for the top 10 indications for saving lives. The further and faster we will ascend. Luckily the top 10 indications are the highest revenue indications. Saving lives is big money. Our future is so bright... I am wearing my sunglasses at night. To quote I believe Cory Hart. For those old rockers. It’s fun to think we are almost there. We are not out of the woods yet but soon... very soon I think. Good times are just around the corner.
After watching Nader’s enthusiasm yesterday and saying that revenue this year is still on the list of great things to happen for us. It’s pretty exciting. The question is... how do we get that revenue? I would like to believe our 75% interim results are powerful enough to unblind them and see where we stand. Either we are getting great results and the road heavily traveled has paid off for us and great things are in our future or we show some average amount of results and we are still saving lives and great things are in our future still. Sounds win/win to me.
Either way, we are on our way to bigger things. The first catalyst or approval will send us on our way to becoming our own pharmaceutical company with so much potential that it is hard to ignore all the possibilities. All the future revenue possibilities are mind boggling.
I invested here with one indication in mind and that was HIV and things have changed dramatically since then with all the possible indications that are possible. I had no idea there would be such a drug like Leronlimab or should I say Virologix.
Getting our first approval speeds up the process of how we go about trialing the other indications and there is so many and that is huge potential.
The old saying is... It takes money to make money. That really holds true as a fledgling pharmaceutical company. Once we can afford to go full tilt on other trials for the top 10 indications for saving lives. The further and faster we will ascend. Luckily the top 10 indications are the highest revenue indications. Saving lives is big money. Our future is so bright... I am wearing my sunglasses at night. To quote I believe Cory Hart. For those old rockers. It’s fun to think we are almost there. We are not out of the woods yet but soon... very soon I think. Good times are just around the corner.
(7)
(1)Scroll down for more posts ▼
